HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isabella Quinti Selected Research

indium oxine

3/2020The Usefulness of Scintigraphic Studies in the Assessment of Asymptomatic Bowel Disease in Patients with Primary Antibody Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isabella Quinti Research Topics

Disease

16Common Variable Immunodeficiency
01/2022 - 04/2003
15Infections
11/2021 - 09/2002
13Primary Immunodeficiency Diseases
01/2022 - 06/2011
10COVID-19
04/2022 - 01/2020
6Bronchiectasis
01/2021 - 02/2005
5Inflammation (Inflammations)
01/2022 - 07/2016
5Agammaglobulinemia (Hypogammaglobulinemia)
01/2021 - 09/2002
4Lung Diseases (Lung Disease)
01/2020 - 05/2007
4Pneumonia (Pneumonitis)
10/2014 - 02/2005
3Bruton type agammaglobulinemia
11/2021 - 06/2011
3Reinfection
01/2021 - 07/2016
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2021 - 02/2005
3Persistent Infection
01/2021 - 07/2008
3Neoplasms (Cancer)
12/2019 - 01/2014
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2018 - 01/2014
2Sudden Infant Death (SID)
09/2021 - 06/2019
2Splenomegaly
01/2021 - 07/2016
2Lymphopenia (Lymphocytopenia)
01/2021 - 01/2016
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2019 - 06/2019
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2019 - 12/2005
2Immune System Diseases (Immune Disorders)
01/2019 - 12/2005
2Lymphoma (Lymphomas)
11/2018 - 07/2008
2Hemolysis
07/2016 - 05/2015
2Pneumococcal Infections
12/2015 - 04/2003
2Ataxia (Dyssynergia)
06/2015 - 01/2014
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2015 - 12/2002
1Atopic Dermatitis (Atopic Eczema)
01/2022
1Chronic Urticaria
01/2022
1Cytopenia
01/2021
1IgA Deficiency
01/2021
1Asymptomatic Diseases
01/2021
1Diarrhea
03/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2019
1Multiple Myeloma
06/2019
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2019
1Hypersensitivity (Allergy)
11/2018
1Tachycardia (Tachyarrhythmias)
03/2017
1Lymphadenopathy
01/2016
1hypohidrotic Ectodermal dysplasia with immune deficiency
12/2015
1Anhidrotic Ectodermal Dysplasia 1
12/2015
1Myasthenia Gravis
01/2014
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2014
1Thrombocytopenia (Thrombopenia)
01/2014
1Hemolytic Anemia
01/2014
1Guillain-Barre Syndrome
01/2014
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2014
1Human Influenza (Influenza)
05/2013
1Septic Shock (Toxic Shock Syndrome)
05/2013
1Rheumatoid Arthritis
05/2013
1Rheumatic Diseases (Rheumatism)
05/2013
1Immunologic Deficiency Syndromes
01/2013

Drug/Important Bio-Agent (IBA)

20Immunoglobulins (Immunoglobulin)IBA
01/2020 - 09/2002
15Immunoglobulin G (IgG)IBA
01/2022 - 09/2002
10Immunoglobulin M (IgM)IBA
01/2021 - 04/2003
10Immunoglobulin A (IgA)IBA
01/2021 - 06/2011
9Intravenous Immunoglobulins (IVIG)FDA Link
01/2019 - 09/2002
7AntibodiesIBA
01/2022 - 02/2005
5VaccinesIBA
11/2021 - 04/2003
5Polysaccharides (Glycans)IBA
01/2021 - 04/2003
3Monoclonal AntibodiesIBA
04/2022 - 01/2021
3BNT162 VaccineIBA
01/2022 - 10/2021
2Immunoglobulin E (IgE)IBA
01/2022 - 11/2018
2AutoantibodiesIBA
01/2022 - 09/2009
2Secretory Immunoglobulin A (SIgA)IBA
01/2021 - 01/2019
2Inosine Triphosphate (ITP)IBA
03/2017 - 01/2014
2Sialic Acid Binding Immunoglobulin-like LectinsIBA
08/2016 - 09/2015
2AntigensIBA
12/2015 - 07/2008
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2015 - 01/2014
1CytokinesIBA
01/2022
1anti-IgE antibodiesIBA
01/2022
1COVID-19 VaccinesIBA
09/2021
1mRNA VaccinesIBA
09/2021
1InterferonsIBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Viral AntigensIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1indium oxineIBA
03/2020
1ibrutinibIBA
12/2019
1Tyrosine Kinase InhibitorsIBA
12/2019
1Pancreatic Elastase (Elastase)IBA
01/2019
1MacrolidesIBA
01/2019
1Azithromycin (Zithromax)FDA LinkGeneric
01/2019
1A-factor (Streptomyces)IBA
11/2018
1IsoantibodiesIBA
07/2016
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
02/2016
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2016
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2016
1LigandsIBA
12/2015
1NF-kappa B (NF-kB)IBA
12/2015
1EctodysplasinsIBA
12/2015
1SteroidsIBA
06/2015
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2014
1Ethanol (Ethyl Alcohol)IBA
01/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2013
1Etanercept (Enbrel)FDA Link
05/2013

Therapy/Procedure

14Therapeutics
01/2022 - 05/2007
1Contraindications
09/2021
1Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2021